News & Updates
Filter by Specialty:
GI symptoms in COVID-19 more prevalent than previously reported
There appears to be a higher prevalence of gastrointestinal (GI) symptoms in hospitalized patients with COVID-19 than previously reported, reveals a recent study.
GI symptoms in COVID-19 more prevalent than previously reported
13 Jan 2022
The 5:2 diet: Is it worth the hype?
The benefits of the 5:2 diet – which involves limited caloric intake (500–600 kcal) for 2 nonconsecutive days per week only – mirrored those achieved with a multicomponent weight management advice, according to a UK study on adults with obesity. However, the benefits eventually waned, even when intensified with group support.
The 5:2 diet: Is it worth the hype?
12 Jan 2022
Lower rates of digestive cancer treatment in older patients due to pandemic lockdowns
The coronavirus disease 2019 (COVID-19) pandemic has led to a sharp decline in treatment for older patients with newly diagnosed cancers of the digestive system, a recent study has found.
Lower rates of digestive cancer treatment in older patients due to pandemic lockdowns
10 Jan 2022
Biologic-naïve IBD patients on anti-TNFα warrant treatment intensification
Treatment intensification is needed in around one-third of biologic-naïve patients with inflammatory bowel disease (IBD) who had received initial antitumour necrosis factor α (anti-TNFα) medication, a recent study has found.
Biologic-naïve IBD patients on anti-TNFα warrant treatment intensification
07 Jan 2022
First-line cabozantinib-atezolizumab boosts PFS in advanced HCC
The combination of cabozantinib and atezolizumab in the first-line setting significantly improved progression-free survival (PFS) compared with sorafenib in patients with advanced hepatocellular carcinoma (HCC), according to results of the phase III COSMIC-312 trial presented at ESMO Asia 2021.
First-line cabozantinib-atezolizumab boosts PFS in advanced HCC
06 Jan 2022
Chronic constipation patients unhappy with conventional treatments: survey
Conventional treatment options for chronic constipation (CC) are not effective enough to improve symptoms or satisfaction among patients, results of an internet survey in Japan have shown.
